Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.19 USD | -0.64% | -0.87% | -10.03% |
09/05 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
28/02 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.03% | 1.79B | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-3.49% | 21.58B | |
-11.30% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Inhibrx Completes Phase 1 Dose Escalation of INBRX-105 in Patients With Solid Tumors, Draws Additional $60 Million in Debt